🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Stocks

UPDATE 1-Box Office: 'Spectre' Tops 'The Peanuts Movie' With $73 Million

Published 2015-11-08, 12:10 p/m
© Reuters.  UPDATE 1-Box Office: 'Spectre' Tops 'The Peanuts Movie' With $73 Million
LCO
-

(Adds details)
By Brent Lang
LOS ANGELES, Nov 8, (Variety.com) - James Bond and Charlie
Brown brought the box office roaring back to life, as "Spectre"
and "The Peanuts Movie" attracted big crowds over their opening
weekends.
"Spectre," the latest 007 adventure, took first place,
debuting to $73 million from 3,929 theaters -- a hefty figure
and the second highest in series history, but one that
nevertheless trails the launch of "Skyfall." The previous film
in the long-running franchise bowed to $88.4 million, but had
better reviews and benefited from being the only new
wide-release in its opening weekend. Going into the weekend,
tracking suggested that the film would debut to $80 million, but
the strength of "The Peanuts Movie" and some critical grousing
may have depressed ticket sales slightly.
Internationally, however, "Spectre" remains a juggernaut,
pulling in $200 million and pushing its worldwide total to more
than $300 million after two weeks in release. With a production
budget of $250 million and millions more in marketing costs,
"Spectre" has to pull in $650 million globally to break even.
It's a time of transition for Bond. Daniel Craig, who was
praised by critics for injecting an emotional depth and danger
to the character, has hinted this is his last time playing the
role.
The search for a replacement has already triggered frenzied
speculation about who can take over the series. And
Metro-Goldwyn-Mayer and Eon Productions are weighing
distribution offers. Sony's deal to distribute the Bond films
expires with "Spectre," and though the studio is expected to
make a bid to keep the series, other suitors, such as Warner
Bros. and Paramount, will aggressively pursue the rights to the
franchise.
While older audiences flocked to see the martini-swilling
spy, Fox's "The Peanuts Movie" appealed to families. The
adaptation of Charles Schulz's beloved comic strip racked up $45
million across 3,897 screens. It cost $100 million to make and
was produced by Blue Sky, the creative force behind the "Ice
Age" series.
On the limited release front, Open Road capitalized on Oscar
buzz for "Spotlight." The look at the Boston Globe's
investigation of the Catholic Church sexual abuse scandal picked
up $302,276 from five theaters. That's a healthy per-screen
average of $60,455.
The film will gradually expand in the coming weeks and hopes
to be in more than 500 theaters heading into Thanksgiving.
"There were multiple sell outs in every theater, every day
this weekend," said Jason Cassidy, chief marketing officer at
Open Road. "They had to add showtimes."
Fox Searchlight offered up another piece of awards bait,
debuting the period romance "Broolyn" in five theaters where it
earned $237,389 and picked up a solid per-screen average of
$36,200.
And Bleecker Street opened "Trumbo," a biopic about
Blacklisted screenwriter Dalton Trumbo with Bryan Cranston, in
five theaters. It picked up $77,229 for a per-screen average of
$15,445, and will expand into Chicago, Boston, Washington D.C.,
Phoenix, San Francisco, and Palm Springs.
"We're prepared for the long run," said Jack Foley,
distribution head at Bleecker Street. "The plan is to go wide at
Thanksgiving and then play out from there."


Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.